Prof. Laura Soucek

Prof. Laura Soucek

ICREA Research Professor at the Vall d’Hebron Institute of Oncology (VHIO), Associate Professor at the Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona

Laura Soucek is ICREA Professor at the Vall d’Hebron Institute of Oncology (VHIO) and Associate Professor at the Universidad Autónoma de Barcelona (UAB) in Barcelona, Spain. All her career has been focused on cancer research and on Myc inhibition strategies. She is also founder and CEO of Peptomyc S.L., a spin off company that aims at treating cancer with anti‐Myc peptides. She completed her undergraduate studies in Biological Sciences at the University La Sapienza, Rome (Italy) in 1996. She was then awarded her PhD in Genetics and Molecular Biology in 2001. That same year, she joined the Comprehensive Cancer Center of the University of California San Francisco (UCSF, USA), where she worked until 2006 as a Postdoctoral Fellow under the mentorship of Gerard Evan. In 2006 she was promoted to Assistant Researcher at the Pathology Department of the University of California San Francisco (UCSF). She joined VHIO in 2011 and was appointed ICREA Research Professor in 2014 and Assistant Professor at the UAB in 2015. She is recipient of prestigious grants and awards, as both first tier scientist and entrepreneur.

 

 

3D mammosphere culture of breast epithelial cell line MCF10A.

Courtesy of Dr. Emer Bourke, NUI Galway

Phospho-Akt expression and localisation

Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Metaphase chromosome spread of Jurkat T-lymphoma cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Apoptosis assessment of SKMES-1 lung cancer cells

Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

HeLa Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

IACR & EACR Joint Conference 2020

26 — 28 February 2020 at Galway Bay Hotel, Galway

Mitotic Chronic Myelogenous Leukaemia K562 Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Cell to Cell Tweeting

Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)

Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.

Confocal Microscopy Analysis

Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

EACR Free Membership

The IACR is an affiliated national society and its members benefit from full membership of the EACR. 

IACR 2022 Conference Registration

Please register by completing our online form.

IACR 2022 Conference Accommodation

B&B Rates and how to get to Radisson Blu Hotel, Cork

Latest News

FACEBOOK

Irish Association
for Cancer Research  

9A Coolkill, Sandyford
Dublin 18, Ireland
D18 C1W3

info@iacr.ie
+353 (0)295 8859

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.

Registered Charity Number (RCN): 20030117.

©Design by LetterEleven